周四，人工智能医疗公司 Tempus AI 盘中股价大涨超15%。消息面上，Tempus AI于今日宣布其更新版的Tempus Pixel心脏成像设备获得美国食品和药物管理局（FDA）的Special 510(k) Clearance（特别510(k)许可）。这一重要的监管里程碑意味着该设备的升级版正式获准在美国商业使用，标志着公司在心脏成像领域取得重大突破。
分析人士认为，FDA的特别许可不仅验证了Tempus AI在医疗技术创新方面的实力，还为公司打开了广阔的市场前景。这一利好消息激发了投资者的信心，推动Tempus AI股价在盘中出现显著上涨。
市场普遍预期，随着新版Tempus Pixel设备的商业化，公司的营收和盈利能力有望得到进一步提升。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
